Found 3 hits for monomerid = 347477 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347477
![PNG](/data/jpeg/tenK34/BindingDB_347477.png) (US9790180, ID 011)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 3
(Homo sapiens (Human)) | BDBM347477
![PNG](/data/jpeg/tenK34/BindingDB_347477.png) (US9790180, ID 011)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 201 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347477
![PNG](/data/jpeg/tenK34/BindingDB_347477.png) (US9790180, ID 011)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |